ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2029

Extended Phenotypic Immunome Characterization (EPIC): A Web-Based Immune Reference Atlas

Joo Guan Yeo1,2, Pan Lu1, Thaschawee Arkachaisri1,2, Su Li Poh1, Fauziah Ally1, Jing Yao Leong3, Kee Thai Yeo1,2, Loshinidevi D/O Thana Bathi1, Yun June Angela Tan2, Seck Choon Elene Lee2 and Salvatore Albani1,4, 1Translational Immunology Institute, Singhealth/Duke-NUS Academic Medical Centre, Singapore Health Services Pte Ltd, Singapore, Singapore, 2KK Women's and Children's Hospital, Singapore, Singapore, 3Translational Immunology Institute, Singhealth/Duke-NUS Academic Medical Centre, Singapore, Singapore, 4Translational Immunology Institute, Singhealth/Duke-NUS Acedemic Medical Centre, Singapore, Singapore

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: CyTOF

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Pediatric Rheumatology – Basic Science Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

An atlas of the developing immune system will aid in our understanding of its normal maturation and identification of disease-associated cell subsets. The availability of high dimensional mass cytometry has provided an opportunity for the creation of this reference standard. However, the power available from these big data has not been fully harnessed due to the current focus on specific cell subsets and age groups. There is a critical unmet need for standardized datasets depicting at single cell level and with high dimensionality the entire developmental gradient of the healthy immune system from the neonatal to adult age.

Methods:

To address this need, we constructed an immune atlas from the mass cytometry data obtained from the peripheral blood mononuclear cell samples of 113 healthy individuals (cord blood, newborn to adult) using 63 phenotypical and functional immune markers encompassing the major immune lineages. Quality control check and batch effect correction were done before dimensional reduction and clustering to identify the unique cell subsets. Their frequencies across the age categories were presented as 3-D frequency histograms to create the immune landscape. This database and the analytic pipeline were incorporated into a web portal that allows user to interact as well as upload their own data for comparison.

Results:

Here, we described EPIC with examples of representative immune subsets over the entire age spectrum. There was a distinct segregation of the naive T cell subset enriched in the cord blood/newborn period from the memory T cell subset enriched in adulthood. The naive IL8+ and TNFα+ CD4+ T cells accounted for prominent peaks in the immune landscape during the cord blood/newborn period. In contrast, the memory IFNγ+ and TNFα+ CD4+ T cells were enriched in adulthood.

Transition developmental milestones were observed in the TNFα+ CD4+ T cells where the size of its memory subset would exceed its naive subset at 8 year old. There was a significant reduction and increase in the frequency of the naive and memory TNFα+ CD4+ T cells with a Spearman’s correlation coefficient, rho, of -0.4662 and 0.4164 respectively (both p < 0.0001). A similar intersection was present for the naive and memory regulatory T cell (CD4+, CD25+, Foxp3+, CD152+) subsets at 14 year old with a rho of -0.537 and 0.5034 respectively (both p < 0.0001).

Conclusion:

A holistic description of the developing immunome was obtained with key developmental milestones in the T cell compartment identified. This atlas has the translational potential of aiding the identification of pathologic immune cell subsets in diseases through its comparison with this reference dataset found in the freely available EPIC web portal.


Disclosure: J. G. Yeo, None; P. Lu, None; T. Arkachaisri, None; S. L. Poh, None; F. Ally, None; J. Y. Leong, None; K. T. Yeo, None; L. D. T. Bathi, None; Y. J. A. Tan, None; S. C. E. Lee, None; S. Albani, None.

To cite this abstract in AMA style:

Yeo JG, Lu P, Arkachaisri T, Poh SL, Ally F, Leong JY, Yeo KT, Bathi LDT, Tan YJA, Lee SCE, Albani S. Extended Phenotypic Immunome Characterization (EPIC): A Web-Based Immune Reference Atlas [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/extended-phenotypic-immunome-characterization-epic-a-web-based-immune-reference-atlas/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/extended-phenotypic-immunome-characterization-epic-a-web-based-immune-reference-atlas/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology